Loading mortality data…

LEV Calculator

Probability of reaching Longevity Escape Velocity — based on age, country, and five expert-weighted hypotheses

35

Statistical estimates based on population-level epidemiological studies — not personal medical advice. Risk factors are combined using an additive excess model (HR = 1 + Σ(HRᵢ−1)), which empirically outperforms the naive multiplicative product for correlated behavioral factors (Mehta et al. 2017 NHANES; Khaw et al. 2008 EPIC-Norfolk). Individual relative risks from: GBD 2019, UK Biobank, Lancet meta-analyses, Holt-Lunstad et al. 2015 (social isolation), GeroScience 2025 meta-analysis (sleep).

What is Longevity Escape Velocity?

LEV is the point at which medical technology can extend a person's remaining life expectancy by more than one year for every year that passes. Once reached, aging becomes a problem that science stays ahead of indefinitely. The concept was popularised by biogerontologist Aubrey de Grey.

What does P(LEV) mean?

It is the probability that LEV is achieved and you are still alive when it happens — weighted across five expert-calibrated scenarios for when LEV might arrive. A high number means: the most likely scenarios for LEV timing align well with your expected remaining lifespan.

What the model does not capture

Survival probabilities are based on population-average mortality tables. They reflect statistical averages across millions of people — not individual circumstances. The model does not account for:

  • Accidents, violence, or other external causes at an individual level
  • Rare or unpredictable events (pandemics, wars, personal illness)
  • Individual genetic or lifestyle factors beyond those in the risk panel

A young person seeing a high probability should read it as: "if nothing unusual happens, the average person your age would likely be alive when LEV arrives." Individual outcomes will vary widely.

How hypothesis weights were chosen

The five scenarios are weighted as follows, with explicit rationale:

  • H1 — Singularity optimist (10%): Kurzweil, Cordeiro, Church predict LEV by ~2030–2035. Historically, this camp has overestimated technological convergence speed by 10–20 years. Included as an upper bound; weighted low.
  • H2 — Biotech optimist (25%): de Grey and Diamandis ground their forecasts in active research programs (senolytics, reprogramming, rapamycin trials). More biologically credible than H1, but still ahead of clinical evidence. Strongest credible near-term case.
  • H3 — Mainstream / Metaculus (38%): The Metaculus community (143 forecasters, median ~2053) is the best single calibration anchor available — a structured aggregation of expert opinion with a track record. Highest weight.
  • H4 — Biological pessimist (19%): Olshansky et al. (Nature Aging, 2024) provide peer-reviewed empirical evidence of a lifespan ceiling; Fedichev's thermodynamic framework adds theoretical grounding. Significant but not dominant.
  • H5 — Does not happen (8%): Irreversibility arguments are serious, but science has repeatedly surpassed assumed limits. Treated as a hard floor — non-negligible but low.

These weights are a calibrated starting point, not scientific consensus. Use the hypothesis trust slider to explore how your conclusions change if you favour different experts.

Uncertainty and limitations

  • The hypotheses are not scientific consensus. They are a best-effort calibration against expert forecasts as of March 2026. The model sensitivity range illustrates how much the result depends on which scenario you believe.
  • Static mortality assumption. The model applies today's mortality rates until LEV arrives, except when the historical trend option is enabled.
  • Both-sexes data. The sex toggle applies an approximate multiplier. Actual sex-specific HMD tables are a planned improvement.
  • This is not medical or financial advice.
P(LEV)
Remaining life expectancy
From current age, HMD period tables
Survival to age 80
From current age
Annual mortality risk now
Probability of dying this year
Your LEV window
Likely range, if you benefit

P(LEV) by age — selected country

Mortality risk (qx) by age — selected country

P(LEV) by country — age

Hypothesis trust Calibrated default
← Optimistic Skeptical →

Drag left to shift weight toward optimistic experts (de Grey, Kurzweil), right toward skeptical ones (Olshansky, Fedichev). The calibrated default reflects our best-effort weighting against Metaculus forecasts.